Benchmark International

Benchmarks Exclusive Opportunities

  • Home
  • Opportunities
  • Buyer Profile
  • About
    • About Us
    • From the Chairman
    • Offices
  • Blog
  • Contact
Primary
  • Home
  • Opportunities
  • Buyer Profile
  • About
    • About Us
    • From the Chairman
    • Offices
  • Blog
  • Contact
  • Home
  • About Us
  • Blog
  • Contact Us
  • From the Chairman
  • Offices
  • Opportunities
  • Stats Dashboard
    • Listing Stats
    • Your Listings

Scientific Consulting Firm Specialized in Regulatory and Compliance Issues – BN000046803

US
2M-5M5M-10M Professional Services / Consultancy
Add Photos
TEASER
CLIENT CODE: BN000046803
REVENUE/TURNOVER: $7,479,000
EBITDA: $2,495,000
HEADQUARTERS: United States
 
Interested? Contact Us
pmanry@benchmarkintl.com
Scientific Consulting Firm Specialized in Regulatory and Compliance Issues – BN000046803

Paul Manry

interested in this opportunity?
Browse My Listings

The company is a full-service scientific consulting firm, specialized in solving complex regulatory and compliance issues. The company provides a variety of services, including Food and Drug Administration (FDA) enforcement support, quality system remediation support, auditing, regulatory strategy, and strategic consulting.

Key Aspects

  • From 2019 to 2022, revenue and adjusted EBITDA grew at compound annual growth rates of 54.0% and 92.4%, respectively
  • Adjusted EBITDA margins averaged 32.9% from 2019 through 2022

Growing pipeline of signed contracts driving revenue in 2023

  • Diverse client base in high-growth industries, with management noting a reoccurring client rate of 87%
  • Lean operating model, with six W2 employees and an expert consultant network of over 200 individuals, with an average 25 years of experience in their respective fields

Opportunities

  • Capitalize on the recent addition of executive-level personnel, enabling the company to take on a greater number of projects
  • Implement a strategic marketing campaign to generate new business, beyond receiving just word-of-mouth referrals, based on the company’s proven client satisfaction record
  • Expand the company’s service offerings and capabilities for clients in the high-growth biologics industry, specifically for cell and gene therapy
  • Strategically expand the company’s expert consultant network to include other regulatory areas the company is not yet involved in

Headquartered

  • United States

Current Markets

  • The company serves a variety of businesses, with a focus on the pharmaceutical, biologics, and medical device industries. The company’s clients are primarily US-based (95%) with the remaining located across the globe.

Real Estate

  • The company operates fully remote with no physical location being leased or owned.

Shareholder Objectives

  • The company is fully owned by a single shareholder who would like to financially de-risk and pursue personal endeavors. The owner is willing to remain with the company for a predetermined amount of time to facilitate a smooth transition of ownership.

You Might Also Like

    AMERICAS HQ

    4030 West Boy Scout Blvd. Suite 500
    Tampa, FL 33609
    +1 813 898 2350
    US@Benchmarkintl.com

    Europe HQ

    101 Park Dr., Milton Park
    Oxfordshire, OX14 4RY
    +44 (0)1865 410 050
    UK@Benchmarkintl.com

    AFRICA HQ

    Ground Floor, Runway 01, Airport Office Park
    Cape Town International Airport, Cape Town, 7525
    +27 21 300 2055
    Africa@Benchmarkintl.com

    Copyright Benchmark International © 2022-2023. All Rights Reserved
    • LinkedIn
    • Twitter
    • Instagram
    • Vimeo
    • YouTube

    Login

    Lost your password?